deferoxamine has been researched along with Bilateral Deafness in 3 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Periodical audiovisual monitoring should be performed on hemodialyzed patients receiving the drug in order to detect adverse effects as early as possible." | 1.28 | Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine. ( Cases, A; Griño, MC; Kelly, J; Lopez-Pedret, J; Revert, L; Sabater, F; Torras, A, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cases, A | 2 |
| Kelly, J | 2 |
| Sabater, F | 1 |
| Torras, A | 2 |
| Griño, MC | 1 |
| Lopez-Pedret, J | 1 |
| Revert, L | 2 |
| Wonke, B | 1 |
| Hoffbrand, AV | 1 |
| Aldouri, M | 1 |
| Wickens, D | 1 |
| Flynn, D | 1 |
| Stearns, M | 1 |
| Warner, P | 1 |
| Sabater, J | 1 |
| Campistol, JM | 1 |
| Montoliu, J | 1 |
| López, I | 1 |
3 other studies available for deferoxamine and Bilateral Deafness
| Article | Year |
|---|---|
Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine.
Topics: Adult; Aged; Aged, 80 and over; Aluminum; Chelation Therapy; Deferoxamine; Female; Hearing Loss, Bil | 1990 |
Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA.
Topics: Adolescent; Adult; Audiometry; Blood Transfusion; Child; Child, Preschool; Deferoxamine; Female; Fer | 1989 |
Acute visual and auditory neurotoxicity in patients with end-stage renal disease receiving desferrioxamine.
Topics: Acute Disease; Adult; Aged; Deferoxamine; Female; Hearing Loss; Hearing Loss, Bilateral; Hearing Los | 1988 |